Ciprofloxacin-susceptible but levofloxacin-resistant Pseudomonas aeruginosa clinical strains with Vitek®2: which mechanism involved and consequences in case of fluoroquinolone treatment?

IF 3 3区 医学 Q2 INFECTIOUS DISEASES European Journal of Clinical Microbiology & Infectious Diseases Pub Date : 2025-03-01 Epub Date: 2024-12-20 DOI:10.1007/s10096-024-05006-3
Manon Robert, Louise Ruffier d'Epenoux, Axelle Paquin, David Boutoille, Aurélie Guillouzouic, Stéphane Corvec
{"title":"Ciprofloxacin-susceptible but levofloxacin-resistant Pseudomonas aeruginosa clinical strains with Vitek<sup>®</sup>2: which mechanism involved and consequences in case of fluoroquinolone treatment?","authors":"Manon Robert, Louise Ruffier d'Epenoux, Axelle Paquin, David Boutoille, Aurélie Guillouzouic, Stéphane Corvec","doi":"10.1007/s10096-024-05006-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Pseudomonas aeruginosa clinical strains isolated harbored sometimes an atypical phenotype using the automated Vitek2<sup>®</sup>: ciprofloxacin-susceptibility but levofloxacin-resistance according to 2019 CA-SFM criteria. The aims of this study are to investigate the resistance mechanism(s) involved and to identify the consequences on fluoroquinolone treatment.</p><p><strong>Methods: </strong>Strain resistance profile, patient's data were recovered and reviewed from the database. Minimum inhibitory concentrations of levofloxacin, ciprofloxacin, moxifloxacin and delafloxacin were determined by using a concentration gradient strip. gyrA, gyrB, parC, parE and mexR genes were PCR amplified and sequenced. A PFGE analysis was performed for strains, recovered in a short period of time from the same patient.</p><p><strong>Results: </strong>46 strains were studied. A couple of seldom mutations were detected in gyrA, gyrB, parC and parE genes. Phenotypically, most of the strains (91%) were resistant to ticarcillin/ clavulanic acid combination and aztreonam suggesting a MexAB-OprM efflux-pump overexpression. mexR sequencing demonstrated either a deletion, a mutation or a premature stop codon appearance leading to amino acid substitution for 75% of the strains. Interestingly, four patients presented successively a fully fluoroquinolone susceptible isolate, thereafter a ciprofloxacin-susceptible but levofloxacin-resistant isolate (discordant phenotype) and finally a fluoroquinolone-resistant isolate. Molecular typing of these strains highlighted a strong relatedness between those isolates.</p><p><strong>Conclusion: </strong>The phenotype detected by the automate Vitek2<sup>®</sup> is linked to a likely efflux-pump overexpression mechanism and not fluoroquinolone-target mutation. Regarding this discordant phenotype, an alert should be provided to clinicians concerning the high risk of selecting a fluoroquinolone-resistant mutant.</p>","PeriodicalId":11782,"journal":{"name":"European Journal of Clinical Microbiology & Infectious Diseases","volume":" ","pages":"549-558"},"PeriodicalIF":3.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology & Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10096-024-05006-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/20 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: Pseudomonas aeruginosa clinical strains isolated harbored sometimes an atypical phenotype using the automated Vitek2®: ciprofloxacin-susceptibility but levofloxacin-resistance according to 2019 CA-SFM criteria. The aims of this study are to investigate the resistance mechanism(s) involved and to identify the consequences on fluoroquinolone treatment.

Methods: Strain resistance profile, patient's data were recovered and reviewed from the database. Minimum inhibitory concentrations of levofloxacin, ciprofloxacin, moxifloxacin and delafloxacin were determined by using a concentration gradient strip. gyrA, gyrB, parC, parE and mexR genes were PCR amplified and sequenced. A PFGE analysis was performed for strains, recovered in a short period of time from the same patient.

Results: 46 strains were studied. A couple of seldom mutations were detected in gyrA, gyrB, parC and parE genes. Phenotypically, most of the strains (91%) were resistant to ticarcillin/ clavulanic acid combination and aztreonam suggesting a MexAB-OprM efflux-pump overexpression. mexR sequencing demonstrated either a deletion, a mutation or a premature stop codon appearance leading to amino acid substitution for 75% of the strains. Interestingly, four patients presented successively a fully fluoroquinolone susceptible isolate, thereafter a ciprofloxacin-susceptible but levofloxacin-resistant isolate (discordant phenotype) and finally a fluoroquinolone-resistant isolate. Molecular typing of these strains highlighted a strong relatedness between those isolates.

Conclusion: The phenotype detected by the automate Vitek2® is linked to a likely efflux-pump overexpression mechanism and not fluoroquinolone-target mutation. Regarding this discordant phenotype, an alert should be provided to clinicians concerning the high risk of selecting a fluoroquinolone-resistant mutant.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
环丙沙星敏感但左氧氟沙星耐药的铜绿假单胞菌临床菌株Vitek®2:氟喹诺酮治疗的机制和后果?
目的:根据2019年CA-SFM标准,铜绿假单胞菌临床分离菌株有时具有非典型表型:环丙沙星敏感性,但左氧氟沙星耐药。本研究的目的是调查所涉及的耐药机制,并确定氟喹诺酮治疗的后果。方法:从数据库中检索菌株耐药谱和患者资料。采用浓度梯度条法测定左氧氟沙星、环丙沙星、莫西沙星和德拉沙星的最低抑菌浓度。对gyrA、gyrB、parC、parE和mexR基因进行PCR扩增和测序。对同一患者短时间内恢复的菌株进行PFGE分析。结果:研究了46株菌株。在gyrA、gyrB、parC和parE基因中检测到少量突变。表型上,大多数菌株(91%)对替卡西林/克拉维酸联合用药和氨曲南耐药,提示MexAB-OprM外排泵过表达。mexR测序显示,75%的菌株存在缺失、突变或过早终止密码子出现,导致氨基酸替代。有趣的是,4例患者先后出现了完全氟喹诺酮敏感的分离株,随后出现了环丙沙星敏感但左氧氟沙星耐药的分离株(表型不一致),最后出现了氟喹诺酮耐药分离株。这些菌株的分子分型突出了这些分离株之间的强烈亲缘关系。结论:自动化Vitek2®检测到的表型可能与外排泵过表达机制有关,而不是氟喹诺酮靶向突变。关于这种不一致的表型,应向临床医生提出警告,注意选择氟喹诺酮耐药突变体的高风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
10.40
自引率
2.20%
发文量
138
审稿时长
1 months
期刊介绍: EJCMID is an interdisciplinary journal devoted to the publication of communications on infectious diseases of bacterial, viral and parasitic origin.
期刊最新文献
Point of care antimicrobial susceptibility testing. Drug resistance trends in Tuberculosis cases: Insights from a decade of surveillance data. Mapping 25 years of research on gut microbiota and antibiotic resistance: bibliometric insights and future directions. LVAD specific infection with Coxiella burnetii treated with heart transplantation and antibiotic suppression. Treatment outcomes of Mycobacterium simiae pulmonary disease: a retrospective multicenter cohort study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1